Faron Pharmaceuticals Oy
F:4FR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Faron Pharmaceuticals Oy
F:4FR
|
FI |
|
M
|
Mondo TV SpA
F:MJE
|
IT |
|
R
|
Reply SpA
F:REJA
|
IT |
|
Emak SpA
MIL:EM
|
IT |
|
PCF Group SA
F:6D1
|
PL |
|
Ouster Inc
NASDAQ:OUST
|
US |
|
KLN Logistics Group Ltd
F:KYL
|
HK |
|
Magazine Luiza SA
OTC:MGLUY
|
BR |
|
R
|
Repsol SA
XHAM:REP
|
ES |
|
Proximar Seafood AS
F:84Q
|
NO |
|
E
|
Exagen Inc
F:E08A
|
US |
|
T
|
Thaire Life Assurance PCL
SET:THREL
|
TH |
|
M
|
Mitsubishi Logistics Corp
DUS:MIB
|
JP |
|
Eurocommercial Properties NV
F:N4SA
|
NL |
|
Arch Capital Group Ltd
NASDAQ:ACGL
|
BM |
|
Jangada Mines PLC
F:JMU
|
UK |
|
P
|
PVA TePla AG
DUS:TPE
|
DE |
|
Iren SpA
F:TZ8
|
IT |
|
JGC Holdings Corp
F:VJC
|
JP |
|
B
|
Bangkok Commercial Asset Management PCL
SET:BAM
|
TH |
|
Leifras Co Ltd
NASDAQ:LFS
|
JP |
|
Rosebank Industries PLC
F:W1E
|
UK |
|
T
|
Tomony Holdings Inc
TSE:8600
|
JP |
|
F
|
Fraser and Neave Ltd
F:FNV2
|
SG |
Bankruptcy Probability
Faron Pharmaceuticals Oy's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Faron Pharmaceuticals Oy Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FI |
|
Faron Pharmaceuticals Oy
LSE:FARN
|
74.1m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Faron Pharmaceuticals Oy's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Faron Pharmaceuticals Oy has total debt of 9.2m EUR. This includes both short-term (0 EUR) and long-term (9.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.